Dong Qian,
Shuai Wang,
Hongzhi Zhao ,
Chen Zhang
For correspondence:- Hongzhi Zhao Email: OmarWoodsgtl@yahoo.com Tel:+862227022268
Accepted: 29 December 2019 Published: 31 January 2020
Citation: Qian D, Wang S, Zhao H, Zhang C. Efficacy and safety of VEGFR inhibitors versus standard chemotherapy in Chinese patients with metastatic liver cancer: Results of a preliminary clinical trial. Trop J Pharm Res 2020; 19(1):189-194 doi: 10.4314/tjpr.v19i1.27
© 2020 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Archives
News Updates